Similar articles

• Hepatic veno-occlusive disease associated with renal transplantation and azathioprine therapy.

  Read AE, Wiesner RH, LaBrecque DR, Tifft JG, Mullen KD, Sheer RL, Petrelli M, Ricanati ES, McCullough AJ. Read AE, et al. Ann Intern Med. 1986 May;104(5):651-5. doi: 10.7326/0003-4819-104-5-651. Ann Intern Med. 1986. PMID: 3008617
• Hepatic veno-occlusive disease and renal transplantation.

  Liaño F, Moreno A, Teruel JL, Lamas S, Matesanz R, Ortuño J. Liaño F, et al. Ann Intern Med. 1986 Oct;105(4):625-6. doi: 10.7326/0003-4819-105-4-625. Ann Intern Med. 1986. PMID: 3530081 No abstract available.
• Hepatic vascular disease after kidney transplantation: report of two cases and review of the literature.

  Adler M, Delhaye M, Deprez C, Hardy N, Gelin M, De Pauw L, Vereerstraeten P, Cremer M, Toussaint C. Adler M, et al. Nephrol Dial Transplant. 1987;2(3):183-8. Nephrol Dial Transplant. 1987. PMID: 3114679
• Successful treatment of severe azathioprine-induced hepatic veno-occlusive disease in a kidney-transplanted patient with transjugular intrahepatic portosystemic shunt.

  Azoulay D, Castaing D, Lemoine A, Samuel D, Majno P, Reynes M, Charpentier B, Bismuth H. Azoulay D, et al. Clin Nephrol. 1998 Aug;50(2):118-22. Clin Nephrol. 1998. PMID: 9725784 Review.
• [Myelodysplastic syndrome (RAEB in T) developed in a renal allograft recipient].

  Shiraishi J, Sudo Y, Katori Y, Akiyama M, Takada O, Maki K, Sawada K, Inaba T, Shimazaki C, Nakagawa M. Shiraishi J, et al. Rinsho Ketsueki. 1998 Aug;39(8):600-5. Rinsho Ketsueki. 1998. PMID: 9785979 Review. Japanese.